Literature DB >> 22582173

Calpain inhibition preserves talin and attenuates right heart failure in acute pulmonary hypertension.

Hasan A Ahmad1, Li Lu, Shuyu Ye, Gregory G Schwartz, Clifford R Greyson.   

Abstract

Right heart failure from right ventricular (RV) pressure overload is a major cause of morbidity and mortality, but its mechanism is incompletely understood. We tested the hypothesis that right heart failure during 4 hours of RV pressure overload is associated with alterations of the focal adhesion protein talin, and that the inhibition of calpain attenuates RV dysfunction and preserves RV talin. Anesthetized open-chest pigs treated with the calpain inhibitor MDL-28170 (n = 20) or inactive vehicle (n = 23) underwent 4 hours of RV pressure overload by pulmonary artery constriction (initial RV systolic pressure, 64 ± 1 and 66 ± 1 mm Hg in MDL-28170 and vehicle-treated pigs, respectively). Progressive RV contractile dysfunction was attenuated by MDL-28170: after 4 hours of RV pressure overload, RV systolic pressure was 44 ± 4 mm Hg versus 49 ± 6 mm Hg (P = 0.011), and RV stroke work was 72 ± 5% of baseline versus 90 ± 5% of baseline, (P = 0.027), in vehicle-treated versus MDL-28170-treated pigs, respectively. MDL-28170 reduced the incidence of hemodynamic instability (death or systolic blood pressure of < 85 mm Hg) by 46% (P = 0.013). RV pressure overload disrupted talin organization. MDL-28170 preserved talin abundance in the RV free wall (P = 0.039), and talin abundance correlated with the maintenance of RV free wall stroke work (r = 0.58, P = 0.0039). α-actinin and vinculin showed similar changes according to immunohistology. Right heart failure from acute RV pressure overload is associated with reduced talin abundance and disrupted talin organization. Calpain inhibition preserves the abundance and organization of talin and RV function. Calpain inhibition may offer clinical utility in treating acute cor pulmonale.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22582173      PMCID: PMC3488694          DOI: 10.1165/rcmb.2011-0286OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  35 in total

Review 1.  Cardiac alternans: mechanisms and pathophysiological significance.

Authors:  D E Euler
Journal:  Cardiovasc Res       Date:  1999-06       Impact factor: 10.787

2.  Troponin I degradation and myocardial stunning.

Authors:  Z Papp; J Barta; G J Stienen
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

Review 3.  The evolving management of acute right-sided heart failure in cardiac transplant recipients.

Authors:  B Stobierska-Dzierzek; H Awad; R E Michler
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

4.  Calpain-mediated proteolysis of talin regulates adhesion dynamics.

Authors:  Santos J Franco; Mary A Rodgers; Benjamin J Perrin; Jaewon Han; David A Bennin; David R Critchley; Anna Huttenlocher
Journal:  Nat Cell Biol       Date:  2004-09-19       Impact factor: 28.824

Review 5.  The right ventricle: anatomy, physiology, and clinical importance.

Authors:  L J Dell'Italia
Journal:  Curr Probl Cardiol       Date:  1991-10       Impact factor: 5.200

6.  Inhibition of the proteolysis of rat erythrocyte membrane proteins by a synthetic inhibitor of calpain.

Authors:  S Mehdi; M R Angelastro; J S Wiseman; P Bey
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

7.  Rat cardiac contractile dysfunction induced by Ca2+ overload: possible link to the proteolysis of alpha-fodrin.

Authors:  T Tsuji; Y Ohga; Y Yoshikawa; S Sakata; T Abe; N Tabayashi; S Kobayashi; H Kohzuki; K I Yoshida; H Suga; S Kitamura; S Taniguchi; M Takaki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

8.  Brief rapid pacing depresses contractile function via Ca(2+)/PKC-dependent signaling in cat ventricular myocytes.

Authors:  Y G Wang; W J Benedict; J Hüser; A M Samarel; L A Blatter; S L Lipsius
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-01       Impact factor: 4.733

Review 9.  The calpain system.

Authors:  Darrell E Goll; ValeryY F Thompson; Hongqi Li; Wei Wei; Jinyang Cong
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

10.  Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure.

Authors:  François Kerbaul; Benoît Rondelet; Sophie Motte; Pierre Fesler; Ives Hubloue; Patricia Ewalenko; Robert Naeije; Serge Brimioulle
Journal:  Crit Care Med       Date:  2004-04       Impact factor: 7.598

View more
  7 in total

1.  Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia.

Authors:  Ashraf A Sabe; Brittany A Potz; Nassrene Y Elmadhun; Yuhong Liu; Jun Feng; M Ruhul Abid; Jinnette D Abbott; Donald R Senger; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2015-09-03       Impact factor: 5.209

2.  Role of Calpain in Pathogenesis of Human Disease Processes.

Authors:  Brittany A Potz; M Ruhul Abid; Frank W Sellke
Journal:  J Nat Sci       Date:  2016

3.  Calpain inhibition modulates glycogen synthase kinase 3β pathways in ischemic myocardium: A proteomic and mechanistic analysis.

Authors:  Brittany A Potz; Ashraf A Sabe; Nassrene Y Elmadhun; Richard T Clements; M Ruhul Abid; Neel R Sodha; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2016-11-16       Impact factor: 5.209

Review 4.  The NO/ONOO-cycle as the central cause of heart failure.

Authors:  Martin L Pall
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

5.  Noncanonical WNT Activation in Human Right Ventricular Heart Failure.

Authors:  Jonathan J Edwards; Jeffrey Brandimarto; Dong-Qing Hu; Sunhye Jeong; Nora Yucel; Li Li; Kenneth C Bedi; Shogo Wada; Danielle Murashige; Hyun Tae V Hwang; Mingming Zhao; Kenneth B Margulies; Daniel Bernstein; Sushma Reddy; Zoltan Arany
Journal:  Front Cardiovasc Med       Date:  2020-10-07

Review 6.  Targeting JP2: A New Treatment for Pulmonary Hypertension.

Authors:  Rubin Tan; Cui Li; Chuan Xu; Qi Wu; Liping Gao; Yue Shi; Jie Cui
Journal:  Oxid Med Cell Longev       Date:  2021-08-06       Impact factor: 6.543

7.  Targeted inhibition of calpain in mitochondria alleviates oxidative stress-induced myocardial injury.

Authors:  Dong Zheng; Ting Cao; Lu-Lu Zhang; Guo-Chang Fan; Jun Qiu; Tian-Qing Peng
Journal:  Acta Pharmacol Sin       Date:  2020-09-23       Impact factor: 7.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.